The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) concluded the Annual Breast Cancer Conference 2024, which united over 250 healthcare professionals, researchers, and experts worldwide to explore the latest detection, treatment, and care advancements.
The two-day conference had the theme, 'Advancing Breast Cancer Care: Innovations in Detection, Treatment, and Management.' Dr Mohamed Salem al-Hassan, CEO and medical director of the NCCCR, opened the ceremony and highlighted the significance of this conference.
The conference provided a significant platform to discuss advanced innovations such as targeted therapies, immunotherapy, and Antibody-Drug Conjugates (ADCs). Attendees engaged in discussions, interactive panels, and comprehensive presentations to enhance understanding and application of these transformative treatments in clinical practice.
Dr Salha Bujassoum al-Bader, chairperson of Medical Oncology and Palliative Care Medicine at NCCCR, director of the Center for Clinical and Precision Medicine and Genomics at HMC, and chair of the Organising Committee, said: "The Annual Breast Cancer Conference 2024 demonstrated our progress in the fight against breast cancer. We witnessed a paradigm shift in treatment approaches that will undoubtedly reshape clinical practices, improve patient experiences, and provide renewed hope and confidence to cancer patients."
The event featured a diverse programme of keynote speeches by international, regional, and local experts, offering comprehensive updates on the latest in breast cancer biology, biomarkers, and management strategies. By bringing together oncologists, surgeons, radiologists, pathologists, primary care physicians, nurses, and other healthcare professionals, the conference created a collaborative environment to bridge the gap between scientific research and real-world clinical practice.
"At HMC, we are committed to fostering global dialogue on the latest advancements in cancer care. This conference allowed us to share the newest innovations in breast cancer management while reinforcing our dedication to improving patient outcomes," added Dr Bujassoum.
"Our mission as medical oncologists is to provide personalised care that addresses patients' physical, psychological, and emotional needs. Advancements in cancer treatment are possible only when we come together as a community of healthcare professionals. The Annual Breast Cancer Conference was an opportunity to exchange knowledge and experiences that can lead to groundbreaking improvements in patient care," concluded, Dr al-Bader.
The two day conference united over 250 healthcare professionals.
